Case Study: How a [STATE] [CLIENT TYPE] Achieved URAC Specialty Pharmacy Accreditation and Entered [PBM] Network
Last updated: April 2026
A [SIZE: e.g., mid-sized independent / hospital outpatient / health system] specialty pharmacy in [STATE] engaged IHS to guide them through URAC Specialty Pharmacy Accreditation v[VERSION]. Within [TIMELINE] months, they achieved Full Accreditation on their first attempt — unlocking [PBM] network inclusion and [NUMBER] new limited distribution drug contracts.
The Challenge
[CLIENT TYPE] faced a critical business problem: without URAC accreditation, they were locked out of [PBM] specialty pharmacy network and unable to access limited distribution drugs from [MANUFACTURER/DRUG CATEGORY]. Their specific challenges included:
- No existing compliance infrastructure: [CLIENT TYPE] had [DESCRIPTION OF STARTING STATE — e.g., basic operational policies but no formal quality management program, no documented patient management workflows, and no performance measurement reporting system].
- Cold-chain documentation gaps: [DESCRIPTION — e.g., temperature monitoring was conducted but not documented in a format that met P-MD module requirements; no temperature qualification testing records existed for shipping lanes].
- Patient Management program deficiency: [DESCRIPTION — e.g., clinical assessments were conducted verbally but not documented in pharmacy management software; care plans were boilerplate rather than individualized].
- Limited internal compliance staff: [DESCRIPTION — e.g., the pharmacy had a Pharmacist-in-Charge and two clinical pharmacists but no dedicated quality assurance or compliance manager].
- Timeline pressure: [DESCRIPTION — e.g., a major PBM contract renewal required accreditation status within 10 months; failure to achieve accreditation would result in network exclusion and loss of approximately $X million in annual revenue].
The IHS Approach
IHS deployed a [TIMELINE]-month engagement structured around the six phases of URAC Specialty Pharmacy Accreditation. Here is what we delivered in each phase.
Phase 1: Standard-by-Standard Review (Months 1-2)
IHS conducted an educational Standard-by-Standard Review of [CLIENT TYPE]'s operations against every applicable v[VERSION] standard across all 9 modules and produced a prioritized remediation roadmap. The review identified [NUMBER] standards requiring new or substantially revised documentation and [NUMBER] areas requiring operational improvement.
- [SPECIFIC GAP FINDING 1 — e.g., OPIN module: Primary Source Verifications were conducted but lacked time-stamped documentation; verification frequency did not match internal policy requirements]
- [SPECIFIC GAP FINDING 2 — e.g., PM module: Patient assessments were documented on paper rather than within pharmacy management software; no individualized care plans existed]
- [SPECIFIC GAP FINDING 3 — e.g., P-MD module: Cold-chain shipping protocols existed but temperature qualification testing had never been formally conducted or documented]
- [SPECIFIC GAP FINDING 4 — e.g., PMI module: Quality Management Committee had never been formally established; no meeting minutes existed]
Phase 2: Document Preparation (Months 2-5)
IHS provided policy templates and assisted [CLIENT TYPE]'s team with customizing [NUMBER] policies and procedures across all applicable standard modules. Key deliverables included:
- [DELIVERABLE 1 — e.g., Complete Patient Management program policy templates, including clinical assessment frameworks, individualized care plan templates, and therapeutic intervention documentation guidelines]
- [DELIVERABLE 2 — e.g., Temperature qualification testing protocols for all shipping lanes with documentation templates meeting P-MD module requirements]
- [DELIVERABLE 3 — e.g., Quality Management Committee charter, meeting agenda templates, and minutes frameworks with root cause analysis and follow-up accountability structures]
- [DELIVERABLE 4 — e.g., Staff competency assessment program covering all clinical and non-clinical roles with annual documentation requirements]
- [DELIVERABLE 5 — e.g., Grievance and complaint packet revision including mandatory state regulatory agency contact information for [STATE]]
Phase 3: Application Submission (Months 5-6)
IHS prepared and reviewed the complete AccreditNet submission package, including scope of services definition, organizational structure documentation, and delegation activity disclosures. We structured the upload to minimize avoidable RFIs by organizing evidence in the exact format URAC reviewers expect.
Phase 4: Desktop Review and RFI Response (Months 6-7)
[CLIENT TYPE] received [NUMBER] RFIs during the desktop review. IHS drafted all RFI responses, addressing each reviewer concern with targeted evidence and revised policy language where needed. [SPECIFIC RFI DETAIL — e.g., One RFI challenged the frequency of Primary Source Verifications; we responded with revised policy language specifying exact verification cadences and supporting audit trail documentation. Another RFI requested additional evidence of individualized care plans; we submitted de-identified patient files demonstrating tailored assessments.]
Phase 5: Validation Review (Month 7-8)
IHS prepared [CLIENT TYPE]'s team for the [FORMAT: on-site / virtual / hybrid] Validation Review with [NUMBER] mock interview sessions and a complete facility walkthrough rehearsal. During the actual review:
- [VALIDATION DETAIL 1 — e.g., All clinical staff demonstrated competence in PM module standards during interviews]
- [VALIDATION DETAIL 2 — e.g., Patient file audits confirmed individualized care plans were in place for all sampled records]
- [VALIDATION DETAIL 3 — e.g., Cold-chain documentation was audit-ready with complete temperature qualification testing records]
- [VALIDATION DETAIL 4 — e.g., Quality Management Committee minutes demonstrated root cause analysis and follow-up accountability]
Phase 6: Committee Decision (Month [X])
[CLIENT TYPE] received Full Accreditation from the URAC Accreditation Committee on the first attempt, [NUMBER] months after engagement kickoff.
Results
[CLIENT TYPE] achieved the following outcomes within [TIMEFRAME] of receiving URAC accreditation:
- PBM network inclusion: [RESULT — e.g., Accepted into OptumRx specialty pharmacy network within 60 days of accreditation, opening access to approximately $X million in annual specialty drug dispensing volume]
- Limited distribution drug access: [RESULT — e.g., Secured dispensing contracts for X limited distribution drugs from Y manufacturers, representing $X in new annual revenue]
- 340B program optimization: [RESULT — if hospital pharmacy: e.g., URAC accreditation enabled specialty pharmacy network participation, allowing the hospital to capture 340B pricing on specialty medications previously dispensed through external pharmacies, generating approximately $X in annual savings]
- Operational improvement: [RESULT — e.g., The Patient Management program documentation frameworks reduced clinical documentation burden by X% while improving assessment completeness; dispensing accuracy exceeded the URAC aggregate benchmark of 99.98%]
- Competitive positioning: [RESULT — e.g., URAC accreditation differentiated CLIENT TYPE from X non-accredited specialty pharmacies in STATE, strengthening positioning for future payer contract negotiations]
Client Perspective
"[CLIENT QUOTE — e.g., IHS took us from zero compliance infrastructure to Full URAC Accreditation in X months. Their Standard-by-Standard Review and policy templates were the difference-maker — our team understood exactly what URAC reviewers expected and had the frameworks to build compliant documentation. We could not have done this without their expertise.]"
Engagement Summary
| Client Type | [CLIENT TYPE — e.g., Independent Specialty Pharmacy / Hospital Outpatient Pharmacy / Health System Specialty Pharmacy] |
| State | [STATE] |
| Accreditation Program | URAC Specialty Pharmacy Accreditation v[VERSION] |
| Engagement Duration | [NUMBER] months |
| Outcome | Full Accreditation — first attempt |
| RFIs Received | [NUMBER] |
| RFIs Resolved | [NUMBER] — all in first round |
| New PBM Network Access | [PBM NAME(S)] |
| New LDD Contracts | [NUMBER] limited distribution drugs |
| Revenue Impact | [DOLLAR AMOUNT] in new annual dispensing volume |
Related Resources
Ready to Get Started?
Schedule a no-obligation Standard-by-Standard Review with IHS. We will assess your current compliance posture against URAC Specialty Pharmacy v6.0 standards and give you a clear roadmap to accreditation — just like we did for [CLIENT TYPE].